Sharp Corp. buy krebskrebs
Start price
17.05.22
/
50%
€1.88
Target price
17.05.23
€2.20
Performance (%)
-24.47%
End price
18.05.23
€1.42
Summary
This prediction ended on 18.05.23 with a price of €1.42. The prediction for Sharp Corp. disappointed with a performance of -24.47%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sharp Corp. | - | - | - | - |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by krebskrebs for this prediction
In the thread Sharp Corp. diskutieren
In the thread Trading Sharp Corp.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten